5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

C120H113F2N25O7 — CID 159812676

IUPAC5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESO=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(O)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCCCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12
InChIInChI=1S/C25H23F2N5O.C25H25N5O2.C24H23N5O.C23H21N5O2.C23H21N5O/c26-25(27)8-10-32(11-9-25)16-17-12-19(15-28-14-17)18-6-7-22-21(13-18)23(31-30-22)24(33)29-20-4-2-1-3-5-20;31-21-8-10-30(11-9-21)16-17-12-19(15-26-14-17)18-6-7-23-22(13-18)24(29-28-23)25(32)27-20-4-2-1-3-5-20;30-24(26-19-7-3-1-4-8-19)23-21-14-17(9-10-22(21)27-28-23)18-13-20(16-25-15-18)29-11-5-2-6-12-29;29-23(25-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)26-27-22)17-12-19(15-24-14-17)28-8-10-30-11-9-28;29-23(25-19-5-2-1-3-6-19)22-20-12-17(7-8-21(20)26-27-22)18-11-16(13-24-14-18)15-28-9-4-10-28/h1-7,12-15H,8-11,16H2,(H,29,33)(H,30,31);1-7,12-15,21,31H,8-11,16H2,(H,27,32)(H,28,29);1,3-4,7-10,13-16H,2,5-6,11-12H2,(H,26,30)(H,27,28);1-7,12-15H,8-11H2,(H,25,29)(H,26,27);1-3,5-8,11-14H,4,9-10,15H2,(H,25,29)(H,26,27)
InChIKeyNLFPBMRQBSQBHI-UHFFFAOYSA-N
MW2055.39 g/mol
LogP21.61
Rot. Bonds23

About 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (PubChem CID 159812676) has the molecular formula C120H113F2N25O7 and a molecular weight of 2055.39 g/mol. Its IUPAC name is 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.

Molecular Properties

Compound Name5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
PubChem CID159812676
Molecular FormulaC120H113F2N25O7
Molecular Weight2055.39 g/mol
Exact Mass2053.92
IUPAC Name5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESO=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(O)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCCCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12
InChIInChI=1S/C25H23F2N5O.C25H25N5O2.C24H23N5O.C23H21N5O2.C23H21N5O/c26-25(27)8-10-32(11-9-25)16-17-12-19(15-28-14-17)18-6-7-22-21(13-18)23(31-30-22)24(33)29-20-4-2-1-3-5-20;31-21-8-10-30(11-9-21)16-17-12-19(15-26-14-17)18-6-7-23-22(13-18)24(29-28-23)25(32)27-20-4-2-1-3-5-20;30-24(26-19-7-3-1-4-8-19)23-21-14-17(9-10-22(21)27-28-23)18-13-20(16-25-15-18)29-11-5-2-6-12-29;29-23(25-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)26-27-22)17-12-19(15-24-14-17)28-8-10-30-11-9-28;29-23(25-19-5-2-1-3-6-19)22-20-12-17(7-8-21(20)26-27-22)18-11-16(13-24-14-18)15-28-9-4-10-28/h1-7,12-15H,8-11,16H2,(H,29,33)(H,30,31);1-7,12-15,21,31H,8-11,16H2,(H,27,32)(H,28,29);1,3-4,7-10,13-16H,2,5-6,11-12H2,(H,26,30)(H,27,28);1-7,12-15H,8-11H2,(H,25,29)(H,26,27);1-3,5-8,11-14H,4,9-10,15H2,(H,25,29)(H,26,27)
InChIKeyNLFPBMRQBSQBHI-UHFFFAOYSA-N
XLogP21.61
TPSA399.01 Ų
H-Bond Donors11
H-Bond Acceptors22
Rotatable Bonds23
Heavy Atoms154
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002055.39
LogP ≤ 521.61
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1022

Analyze 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The IUPAC name of 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (CID 159812676) is 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.
What is the SMILES notation for 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The canonical SMILES for 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC(O)CC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCCCC4)c3)cc12.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12.
What is the InChIKey of 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The InChIKey is NLFPBMRQBSQBHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H23F2N5O.C25H25N5O2.C24H23N5O.C23H21N5O2.C23H21N5O/c26-25(27)8-10-32(11-9-25)16-17-12-19(15-28-14-17)18-6-7-22-21(13-18)23(31-30-22)24(33)29-20-4-2-1-3-5-20;31-21-8-10-30(11-9-21)16-17-12-19(15-26-14-17)18-6-7-23-22(13-18)24(29-28-23)25(32)27-20-4-2-1-3-5-20;30-24(26-19-7-3-1-4-8-19)23-21-14-17(9-10-22(21)27-28-23)18-13-20(16-25-15-18)29-11-5-2-6-12-29;29-23(25-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)26-27-22)17-12-19(15-24-14-17)28-8-10-30-11-9-28;29-23(25-19-5-2-1-3-6-19)22-20-12-17(7-8-21(20)26-27-22)18-11-16(13-24-14-18)15-28-9-4-10-28/h1-7,12-15H,8-11,16H2,(H,29,33)(H,30,31);1-7,12-15,21,31H,8-11,16H2,(H,27,32)(H,28,29);1,3-4,7-10,13-16H,2,5-6,11-12H2,(H,26,30)(H,27,28);1-7,12-15H,8-11H2,(H,25,29)(H,26,27);1-3,5-8,11-14H,4,9-10,15H2,(H,25,29)(H,26,27).
What are the key properties of 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide has a molecular weight of 2055.39 g/mol, XLogP of 21.61, 23 rotatable bonds, 11 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-phenyl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-phenyl-1H-indazole-3-carboxamide;N-phenyl-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is sourced from PubChem (CID 159812676), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).